Prevalence of depression during the COVID-19 outbreak: A meta-analysis of community-based studies
Hospital Universitario Miguel Servet · Centro de Investigación Biomédica en Red de Salud Mental · +4 more institutions
Abstract
COVID-19 pandemic, declared on March 11, 2020, constitute an extraordinary health, social and economic global challenge. The impact on people's mental health is expected to be high. This paper sought to systematically review community-based studies on depression conducted during the COVID-19 and estimate the pooled prevalence of depression. Method: We searched for cross-sectional, community-based studies listed on PubMed or Web of Science from January 1, 2020 to May 8, 2020 that reported prevalence of depression. A random effect model was used to estimate the pooled proportion of depression.
A total of 12 studies were included in the meta-analysis, with prevalence rates of depression ranging from 7.45% to 48.30%. The pooled prevalence of depression was 25% (95% CI: 18% − 33%), with significant heterogeneity between studies (I2 = 99.60%, p
Citation impact
- FWCI
- 59.50
- Percentile
- 100%
- References
- 50
Authors
6- JBJuan Bueno‐Notivol
Hospital Universitario Miguel Servet
- PGPatricia Gracia‐García
Centro de Investigación Biomédica en Red de Salud Mental, Hospital Universitario Miguel Servet
- BOBeatriz OlayaCorresponding
Parc Sanitari Sant Joan de Déu, Centro de Investigación Biomédica en Red de Salud Mental, Universitat de Barcelona
- ILIsabel Lasheras
Universidad de Zaragoza
- RLRaúl López‐Antón
Centro de Investigación Biomédica en Red de Salud Mental, Universidad de Zaragoza, Instituto de Investigación Sanitaria Aragón
Topics & keywords
- Depression (economics)
- Mental health
- Coronavirus disease 2019 (COVID-19)
- Meta-analysis
- Pandemic
- Public health
- Demography
- Global health
- Good health and well-being
Funding
- ECEuropean CommissionAwards: 2020., COVID-19
- GDGeneralitat de CatalunyaAward: SLT006/17/00066
- MDMinisterio de Economía y CompetitividadAwards: 94/1562, 01/0255, 97/1321E, 98/0103, 03/0815, 06/0617, G03/128
- GDGobierno de Aragón
- IDInstituto de Salud Carlos IIIAwards: 06/0617, 94/1562, 97/1321E, 98/0103, 01/0255, 03/0815, 06/0617, G03/128, 97/1321E, G03/128, 94/1562, 03/0815, 98/0103, 01/0255, 94/1562, 97/1321E, 98/0103, 01/0255, 03/0815, 06/0617, G03/128 and 19/01874
- EREuropean Regional Development Fund
- DDDepartament de Salut, Generalitat de Catalunya